Peter Steven St Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Peter Steven St.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Peter Steven St. Peter Steven St is Director in PHARMATHENE, INC ($PIP) and Director in Omrix Biopharmaceuticals, Inc. ($OMRI) and PRESIDENT AND CEO in ARATANA THERAPEUTICS, INC. ($PETX).
Latest Insider Trading Transactions of Peter Steven St
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALT, PETX, OMRI
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17 2018 | PETX | ARATANA THERAPEUTI ... | St Peter Steven | PRESIDENT AND CEO | Sell | S | 5.85 | 46,094 | 269,788 | 516,626 | 562.7 K to 516.6 K (-8.19 %) |
| Oct 31 2018 | PETX | ARATANA THERAPEUTI ... | St Peter Steven | PRESIDENT AND CEO | Sell | S | 5.86 | 11,513 | 67,454 | 562,720 | 574.2 K to 562.7 K (-2.00 %) |
| Sep 21 2018 | PETX | ARATANA THERAPEUTI ... | St Peter Steven | PRESIDENT AND CEO | Sell | S | 6.06 | 75,000 | 454,305 | 574,233 | 649.2 K to 574.2 K (-11.55 %) |
| Jul 30 2018 | PETX | ARATANA THERAPEUTI ... | St Peter Steven | PRESIDENT AND CEO | Sell | S | 4.33 | 11,513 | 49,842 | 649,233 | 660.7 K to 649.2 K (-1.74 %) |
| Apr 30 2018 | PETX | ARATANA THERAPEUTI ... | St Peter Steven | PRESIDENT AND CEO | Buy | S | 5.00 | 11,513 | 57,582 | 660,746 | 649.2 K to 660.7 K (+1.77 %) |
| Feb 01 2018 | PETX | ARATANA THERAPEUTI ... | St Peter Steven | PRESIDENT AND CEO | Sell | S | 4.77 | 19,367 | 92,301 | 672,259 | 691.6 K to 672.3 K (-2.80 %) |
| Jan 26 2018 | PETX | ARATANA THERAPEUTI ... | St Peter Steven | PRESIDENT AND CEO | Option Exercise | A | 4.83 | 205,000 | 990,150 | 205,000 | |
| Jan 26 2018 | PETX | ARATANA THERAPEUTI ... | St Peter Steven | PRESIDENT AND CEO | Grant | A | 0.00 | 135,600 | 0 | 691,626 | 556 K to 691.6 K (+24.39 %) |
| Dec 21 2017 | PETX | ARATANA THERAPEUTI ... | St Peter Steven | PRESIDENT AND CEO | Option Exercise | M | 3.14 | 26,667 | 83,734 | 86,667 | |
| Dec 21 2017 | PETX | ARATANA THERAPEUTI ... | St Peter Steven | PRESIDENT AND CEO | Buy | M | 3.14 | 26,667 | 83,734 | 556,026 | 529.4 K to 556 K (+5.04 %) |
| Nov 13 2017 | PETX | ARATANA THERAPEUTI ... | St Peter Steven | PRESIDENT AND CEO | Sell | S | 7.00 | 50,000 | 350,000 | 529,359 | 579.4 K to 529.4 K (-8.63 %) |
| Oct 04 2017 | PETX | ARATANA THERAPEUTI ... | St Peter Steven | PRESIDENT AND CEO | Sell | S | 6.24 | 50,000 | 312,115 | 579,359 | 629.4 K to 579.4 K (-7.94 %) |
| Apr 18 2017 | PETX | ARATANA THERAPEUTI ... | St Peter Steven | PRESIDENT AND CEO | Option Exercise | M | 3.14 | 46,666 | 146,531 | 113,334 | |
| Apr 18 2017 | PETX | ARATANA THERAPEUTI ... | St Peter Steven | PRESIDENT AND CEO | Buy | M | 3.14 | 46,666 | 146,531 | 629,359 | 582.7 K to 629.4 K (+8.01 %) |
| Apr 18 2017 | PETX | ARATANA THERAPEUTI ... | St Peter Steven | PRESIDENT AND CEO | Sell | S | 5.54 | 50,000 | 277,150 | 582,693 | 632.7 K to 582.7 K (-7.90 %) |
| Jan 31 2017 | PETX | ARATANA THERAPEUTI ... | St Peter Steven | PRESIDENT AND CEO | Sell | S | 7.72 | 50,000 | 385,875 | 632,693 | 682.7 K to 632.7 K (-7.32 %) |
| Jan 17 2017 | PETX | ARATANA THERAPEUTI ... | St Peter Steven | PRESIDENT AND CEO | Option Exercise | A | 8.02 | 185,000 | 1,483,700 | 185,000 | |
| Jan 17 2017 | PETX | ARATANA THERAPEUTI ... | St Peter Steven | PRESIDENT AND CEO | Grant | A | 0.00 | 139,900 | 0 | 682,693 | 542.8 K to 682.7 K (+25.77 %) |
| Jan 05 2017 | PIP | PHARMATHENE, INC | St Peter Steven | Director | Option Exercise | M | 2.20 | 20,000 | 44,000 | 0 | |
| Jan 05 2017 | PIP | PHARMATHENE, INC | St Peter Steven | Director | Option Exercise | M | 3.11 | 20,000 | 62,200 | 0 | |
| Jan 05 2017 | PIP | PHARMATHENE, INC | St Peter Steven | Director | Option Exercise | M | 2.47 | 20,000 | 49,400 | 0 | |
| Jan 05 2017 | PIP | PHARMATHENE, INC | St Peter Steven | Director | Option Exercise | M | 2.59 | 10,000 | 25,900 | 0 | |
| Jan 05 2017 | PIP | PHARMATHENE, INC | St Peter Steven | Director | Buy | M | 2.20 | 20,000 | 44,000 | 205,004 | 185 K to 205 K (+10.81 %) |
| Jan 05 2017 | PIP | PHARMATHENE, INC | St Peter Steven | Director | Buy | M | 3.11 | 20,000 | 62,200 | 185,004 | 165 K to 185 K (+12.12 %) |
| Jan 05 2017 | PIP | PHARMATHENE, INC | St Peter Steven | Director | Buy | M | 2.47 | 20,000 | 49,400 | 165,004 | 145 K to 165 K (+13.79 %) |
| Jan 05 2017 | PIP | PHARMATHENE, INC | St Peter Steven | Director | Buy | M | 2.59 | 10,000 | 25,900 | 145,004 | 135 K to 145 K (+7.41 %) |
| Dec 16 2016 | PETX | ARATANA THERAPEUTI ... | St Peter Steven | PRESIDENT AND CEO | Sell | S | 7.63 | 50,000 | 381,380 | 542,793 | 592.8 K to 542.8 K (-8.43 %) |
| Dec 16 2016 | PETX | ARATANA THERAPEUTI ... | St Peter Steven | PRESIDENT AND CEO | Gift | G | 0.00 | 50,000 | 0 | 592,793 | 642.8 K to 592.8 K (-7.78 %) |
| Sep 20 2016 | PIP | PHARMATHENE, INC | St Peter Steven | Director | Option Exercise | M | 1.69 | 20,000 | 33,800 | 0 | |
| Sep 20 2016 | PIP | PHARMATHENE, INC | St Peter Steven | Director | Option Exercise | M | 1.81 | 10,004 | 18,107 | 0 | |
| Sep 20 2016 | PIP | PHARMATHENE, INC | St Peter Steven | Director | Option Exercise | M | 1.51 | 20,000 | 30,200 | 0 | |
| Sep 20 2016 | PIP | PHARMATHENE, INC | St Peter Steven | Director | Option Exercise | M | 1.64 | 20,000 | 32,800 | 0 | |
| Sep 20 2016 | PIP | PHARMATHENE, INC | St Peter Steven | Director | Option Exercise | M | 1.45 | 20,000 | 29,000 | 0 | |
| Sep 20 2016 | PIP | PHARMATHENE, INC | St Peter Steven | Director | Option Exercise | M | 1.60 | 20,000 | 32,000 | 0 | |
| Sep 20 2016 | PIP | PHARMATHENE, INC | St Peter Steven | Director | Buy | M | 1.69 | 20,000 | 33,800 | 135,004 | 115 K to 135 K (+17.39 %) |
| Sep 20 2016 | PIP | PHARMATHENE, INC | St Peter Steven | Director | Buy | M | 1.81 | 10,004 | 18,107 | 115,004 | 105 K to 115 K (+9.53 %) |
| Sep 20 2016 | PIP | PHARMATHENE, INC | St Peter Steven | Director | Buy | M | 1.51 | 20,000 | 30,200 | 105,000 | 85 K to 105 K (+23.53 %) |
| Sep 20 2016 | PIP | PHARMATHENE, INC | St Peter Steven | Director | Buy | M | 1.64 | 20,000 | 32,800 | 85,000 | 65 K to 85 K (+30.77 %) |
| Sep 20 2016 | PIP | PHARMATHENE, INC | St Peter Steven | Director | Buy | M | 1.45 | 20,000 | 29,000 | 65,000 | 45 K to 65 K (+44.44 %) |
| Sep 20 2016 | PIP | PHARMATHENE, INC | St Peter Steven | Director | Buy | M | 1.60 | 20,000 | 32,000 | 45,000 | 25 K to 45 K (+80.00 %) |
| Aug 10 2016 | PETX | ARATANA THERAPEUTI ... | St Peter Steven | PRESIDENT AND CEO | Sell | S | 9.25 | 50,000 | 462,500 | 642,793 | 692.8 K to 642.8 K (-7.22 %) |
| Jun 03 2016 | PIP | PHARMATHENE, INC | St Peter Steven | Director | Option Exercise | A | 2.20 | 20,000 | 44,000 | 20,000 | |
| Jan 26 2016 | PETX | ARATANA THERAPEUTI ... | St Peter Steven | PRESIDENT AND CEO | Option Exercise | A | 3.14 | 160,000 | 502,400 | 160,000 | |
| Jan 26 2016 | PETX | ARATANA THERAPEUTI ... | St Peter Steven | PRESIDENT AND CEO | Grant | A | 0.00 | 97,500 | 0 | 792,793 | 695.3 K to 792.8 K (+14.02 %) |
| Aug 04 2015 | PIP | PHARMATHENE, INC | St Peter Steven | Director | Option Exercise | A | 1.69 | 20,000 | 33,800 | 20,000 | |
| Mar 23 2015 | PIP | PHARMATHENE, INC | St Peter Steven | Director | Buy | P | 1.65 | 25,000 | 41,213 | 25,000 | 0 to 25 K |
| Aug 14 2007 | OMRI | Omrix Biopharmaceu ... | St Peter Steven | Director | Option Exercise | M | 12.27 | 2,750 | 33,743 | 8,250 | |
| Aug 14 2007 | OMRI | Omrix Biopharmaceu ... | St Peter Steven | Director | Sell | S | 29.49 | 2,750 | 81,098 | 2,000 | 4.8 K to 2 K (-57.89 %) |
| Aug 14 2007 | OMRI | Omrix Biopharmaceu ... | St Peter Steven | Director | Buy | M | 12.27 | 2,750 | 33,743 | 4,750 | 2 K to 4.8 K (+137.50 %) |
Page: 1